Skip to main content
. 2013 Apr 24;6(1):130–134. doi: 10.3892/ol.2013.1317

Table I.

p53 immunoreactivity in human gliomas.

Grade Immunonegative cases, n (%) Immunopositive cases, n (%)
+ ++ +++ Total
I 7 (77.8) 1 (11.1) 1 (11.1) 0 (0.00) 2 (22.2)
II 16 (28.6) 11 (19.6) 12 (21.4) 17 (30.4) 40 (71.4)
III 14 (26.9) 11 (21.2) 11 (21.2) 16 (30.8) 38 (73.1)
IV 14 (40.0) 3 (8.6) 6 (17.1) 12 (34.3) 21 (60.0)

P<0.05, grade I vs. II, III, and IV (χ2 test).